Consumers should also watch for red flags indicating problematic products or marketing: companies making pharmaceutical equivalence claims, dramatic before-and-after weight loss promises, proprietary blend language hiding strain disclosure, astronomical CFU counts emphasized without research context, and guarantee windows too short to allow realistic assessment (under 60 days)
Evidence of Anti-Inflammatory Benefits: Studies have demonstrated that GLP-1 receptor agonists can lower markers of inflammation in the body, such as C-reactive protein (CRP)
doi:10.3389/fendo.2019.00155 Lau J et al
This biological shift is why the medication is so effective for weight lossit addresses the neurological component of overeating, not just the calories
T., Wilken, M., & Orskov, H